Art

J-GLOBAL ID：201702235725245827   Reference number：17A0791050

Adjuvant Chemotherapy with Gemcitabine for Resected Biliary Tract Cancer : A Single-Arm Phase 2 Study

切除後の胆管癌に対するゲムシタビンを用いた術後化学療法:単群第2相試験

Author (11)： KITAGAWA Noriyuki (First Department of Surgery, Shinshu University School of Medicine) ,  MOTOYAMA Hiroaki (First Department of Surgery, Shinshu University School of Medicine) ,  KOBAYASHI Akira (First Department of Surgery, Shinshu University School of Medicine) ,  YOKOYAMA Takahide (First Department of Surgery, Shinshu University School of Medicine) ,  SHIMIZU Akira (First Department of Surgery, Shinshu University School of Medicine) ,  NOTAKE Tsuyoshi (First Department of Surgery, Shinshu University School of Medicine) ,  FUKUSHIMA Kentaro (First Department of Surgery, Shinshu University School of Medicine) ,  MASUO Hitoshi (First Department of Surgery, Shinshu University School of Medicine) ,  YOSHIZAWA Takahiro (First Department of Surgery, Shinshu University School of Medicine) ,  TSUKAHARA Teruomi (Department of Preventive Medicine and Public Health, Shinshu University School of Medicine) ,  MIYAGAWA Shin-ichi (First Department of Surgery, Shinshu University School of Medicine)
Material： 信州医学雑誌  (Shinshu Medical Journal)
Volume： 65  Issue： 2  Page： 99-111(J-STAGE)  Publication year： 2017 
JST Material Number： G0594A  ISSN： 0037-3826  CODEN： SIZAA7  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *bile duct tumor ,...
Semi thesaurus term： postoperative chemotherapy ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0791050&from=J-GLOBAL&jstjournalNo=G0594A") }}

Author keywords (3)： biliary tract cancer ,  adjuvant chemotherapy ,  gemcitabine

JST classification (2)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Tumors(=neoplasms)of digestive system  (GH04000D)

Substance index (1)： Gemcitabine

Reference (56)：

• 1) Tamandl D, Herberger B, Gruenberger B, Puhalla H, Klinger M, Gruenberger T : Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma. Ann Surg Oncol 15 : 2787-2794, 2008
• 2) Jonas S, Thelen A, Benckert C, Biskup W, Neumann U, Rudolph B, Lopez-Haanninen E, Neuhaus P : Extended liver resection for intrahepatic cholangiocarcinoma : A comparison of the prognostic accuracy of the fifth and sixth editions of the TNM classification. Ann Surg 249 : 303-309, 2009
• 3) Ercolani G, Vetrone G, Grazi GL, Aramaki O, Cescon M, Ravaioli M, Serra C, Brandi G, Pinna AD : Intrahepatic cholangiocarcinoma : primary liver resection and aggressive multimodal treatment of recurrence significantly prolong survival. Ann Surg 252 : 107-114, 2010
• 4) Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okaya T, Shinmura K, Nakajima N : Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 189 : 575-583, 1999
• 5) Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, Yamasaki S, Takayama T, Makuuchi M : Prognostic factors of surgical resection in middle and distal bile duct cancer : an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 137 : 396-402, 2005

Terms in the title (4)： 胆管癌 ,  ゲムシタビン ,  術後化学療法 ,  第2相試験